AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giraud, A.
Right arrow Articles by Taddei, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giraud, A.
Right arrow Articles by Taddei, F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2002, p. 863-865, Vol. 46, No. 3
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.3.863-865.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Mutator Bacteria as a Risk Factor in Treatment of Infectious Diseases{dagger}

Antoine Giraud,1,2 Ivan Matic,2 Miroslav Radman,2 Michel Fons,1 and François Taddei2*

UEPSD-FBI, Bat 440-CRJ-Institut National de la Recherche Agronomique, 78352 Jouy-en-Josas,1 E9916, Institut National de la Santé et de la Recherche Médicale, Faculté de Médecine "Necker-Enfants Malades," Université René Descartes Paris V, 75015 Paris, France2

Received 2 July 2001/ Returned for modification 4 September 2001/ Accepted 19 November 2001

We show in a gnotobiotic mouse model that, in addition to direct selection of antibiotic-resistant bacteria, some antibiotic treatments also select for mutator alleles. Because of these mutator alleles' high mutation rates, the initial treatment failure increases the probability of failures in subsequent treatments with other drugs.


* Corresponding author. Mailing address: E9916, Institut National de la Santé et de la Recherche Médicale, Faculté de Médecine "Necker-Enfants Malades," Université René Descartes Paris V, 156 rue de Vaugirard, 75015 Paris, France. Phone: 33 (0) 1 40 61 53 23. Fax: 33 (0) 1 40 61 53 24. E-mail: taddei{at}necker.fr.

{dagger} Dedicated to the memory of J. Bjorkman.


Antimicrobial Agents and Chemotherapy, March 2002, p. 863-865, Vol. 46, No. 3
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.3.863-865.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2002 by the American Society for Microbiology. All rights reserved.